Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
1(5%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
5%
Ph phase_2
2
10%
Ph phase_3
7
33%
Ph not_applicable
5
24%
Ph phase_4
2
10%

Phase Distribution

1

Early Stage

2

Mid Stage

9

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
2(11.8%)
Phase 3Large-scale testing
7(41.2%)
Phase 4Post-market surveillance
2(11.8%)
N/ANon-phased studies
5(29.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(3)
Completed(13)
Terminated(1)
Other(4)

Detailed Status

Completed13
unknown4
Not yet recruiting2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.9%)
Phase 22 (11.8%)
Phase 37 (41.2%)
Phase 42 (11.8%)
N/A5 (29.4%)

Trials by Status

completed1362%
not_yet_recruiting210%
withdrawn15%
unknown419%
recruiting15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07020429Not Applicable

Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency

Not Yet Recruiting
NCT06679816Phase 4

Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors

Recruiting
NCT06067529

A Multicenter Observational Study on the Development and Health Effects of Premature Ovarian Insufficiency

Unknown
NCT04704141

Relationship of the Microenvironment and Male Fertility

Not Yet Recruiting
NCT05050981

Effects of Menopause Hormonal Therapy and Selective Serotonin Reuptake Inhibitor on Cognition, Sexual Function and Quality of Life

Completed
NCT03578172Not Applicable

HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients

Completed
NCT04962386

Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD

Unknown
NCT02922348Phase 3

Hormone Replacement for Premature Ovarian Insufficiency

Withdrawn
NCT00000559Phase 3

Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

Completed
NCT00000555Phase 3

Women's Angiographic Vitamin and Estrogen Trial (WAVE)

Completed
NCT00041431Not Applicable

Estrogen, Cytokines and Heart Failure in Women

Completed
NCT00000611Phase 3

Women's Health Initiative (WHI)

Completed
NCT00000549Phase 3

Estrogen Replacement and Atherosclerosis (ERA) in Older Women

Completed
NCT00000601Phase 3

Postmenopausal Hormone Therapy in Unstable Angina

Completed
NCT00000605Phase 3

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

Completed
NCT00000399Phase 2

Bone Estrogen Strength Training

Completed
NCT01742533Phase 1

Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure

Unknown
NCT00061711Not Applicable

Alternative Therapies for Menopause: A Randomized Trial

Completed
NCT00252408Phase 4

Danish Osteoporosis Prevention Study

Completed
NCT00825617Not Applicable

Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
21